Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
BMC Public Health
|
July 24, 2025
Transgender healthcare with challenges, disparities, and the path forward: a retrospective study at a tertiary care hospital in Paris, France
Théo Chevallier, Nadia Valin, Giovanna Magrini, et al.
Travel Medicine and Infectious Disease
|
August 31, 2019
Cases of malaria in travellers with sickle cell disease - Chemoprophylaxis is important for this risk group
Claude Bachmeyer, Olivier Steichen, Alicia Moreno-Sabater, et al.
BMC Infectious Diseases
|
November 30, 2016
Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis
Nadia Valin, Laurent Fonquernie, Anne Daguenel, et al.
Sexually Transmitted Diseases
|
October 28, 2009
Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient
Karine Cury, Nadia Valin, Joël Gozlan, et al.
AIDS (London, England)
|
June 16, 2010
Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients
Nadia Valin, Jérôme Pacanowski, Lise Denoeud, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 2, 2023
APOBEC-Induced Mutations at Initiation of Cabotegravir + Rilpivirine for Two Patients Infected by HIV-1 Subtype CRF02: The Interest of Systematic Genotyping
Bruce Shinga Wembulua, Nadia Valin, Sidonie Lambert-Niclot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2024
A HIV Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine
Nadia Valin, Sidonie Lambert-Niclot, Emma Torres, et al.
Diabetes & Metabolism
|
March 2, 2026
Severe hyperglycemia after initiation of long-acting cabotegravir in two antiretroviral treatment-controlled people with HIV
Nadia Valin, Pauline Campa, Thibault Chiarabini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 17, 2014
Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients
Laure Surgers, Nadia Valin, Céline Viala, et al.
The Journal of Infection
|
July 26, 2016
Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy
Juliette Guitard, Marie-Dominique Tabone, Yaye Senghor, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
BMC Public Health
|
July 24, 2025
Transgender healthcare with challenges, disparities, and the path forward: a retrospective study at a tertiary care hospital in Paris, France
Théo Chevallier, Nadia Valin, Giovanna Magrini, et al.
Travel Medicine and Infectious Disease
|
August 31, 2019
Cases of malaria in travellers with sickle cell disease - Chemoprophylaxis is important for this risk group
Claude Bachmeyer, Olivier Steichen, Alicia Moreno-Sabater, et al.
BMC Infectious Diseases
|
November 30, 2016
Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis
Nadia Valin, Laurent Fonquernie, Anne Daguenel, et al.
Sexually Transmitted Diseases
|
October 28, 2009
Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient
Karine Cury, Nadia Valin, Joël Gozlan, et al.
AIDS (London, England)
|
June 16, 2010
Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients
Nadia Valin, Jérôme Pacanowski, Lise Denoeud, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 2, 2023
APOBEC-Induced Mutations at Initiation of Cabotegravir + Rilpivirine for Two Patients Infected by HIV-1 Subtype CRF02: The Interest of Systematic Genotyping
Bruce Shinga Wembulua, Nadia Valin, Sidonie Lambert-Niclot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2024
A HIV Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine
Nadia Valin, Sidonie Lambert-Niclot, Emma Torres, et al.
Diabetes & Metabolism
|
March 2, 2026
Severe hyperglycemia after initiation of long-acting cabotegravir in two antiretroviral treatment-controlled people with HIV
Nadia Valin, Pauline Campa, Thibault Chiarabini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 17, 2014
Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients
Laure Surgers, Nadia Valin, Céline Viala, et al.
The Journal of Infection
|
July 26, 2016
Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy
Juliette Guitard, Marie-Dominique Tabone, Yaye Senghor, et al.
Page
of 6